{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:49:31Z","timestamp":1778071771560,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jocn.2016.10.046","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T09:58:53Z","timestamp":1479290333000},"page":"43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Buzz Juice: Neurological sequelae of synthetic cannabinoids"],"prefix":"10.1016","volume":"37","author":[{"given":"Manisha","family":"Kak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadi","family":"Mikhail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho T.","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimas V.","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2016.10.046_b0005","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/hipo.22213","article-title":"Deficits following treatment with JWH-081, a new component of spice\/K2 preparations","volume":"24","author":"Basavarajappa","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.jocn.2016.10.046_b0010","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4062\/biomolther.2015.057","article-title":"Neurotoxicity of synthetic cannabinoids JWH-081 and JWH-210","volume":"23","author":"Cha","year":"2015","journal-title":"Biomol Ther"},{"key":"10.1016\/j.jocn.2016.10.046_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jocn.2016.10.046_b0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00062-010-0022-9","article-title":"Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR imaging and clinical features in three patients","volume":"20","author":"Blasel","year":"2010","journal-title":"Neuroradiology"},{"key":"10.1016\/j.jocn.2016.10.046_b0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.psc.2013.02.008","article-title":"Toluene abuse and white matter: a model of toxic leukoencephalopathy","volume":"36","author":"Filley","year":"2013","journal-title":"Psychiatric Clin N Am"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816307731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586816307731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T13:52:06Z","timestamp":1536241926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586816307731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":5,"alternative-id":["S0967586816307731"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2016.10.046","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buzz Juice: Neurological sequelae of synthetic cannabinoids","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2016.10.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}